124 related articles for article (PubMed ID: 20565336)
1. Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold.
Tu G; Xiong F; Huang H; Kuang B; Li S
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):222-30. PubMed ID: 20565336
[TBL] [Abstract][Full Text] [Related]
2. Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands.
Lee SH; Seo HJ; Kim MJ; Kang SY; Song KS; Lee SH; Jung ME; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Apr; 19(7):1899-902. PubMed ID: 19269817
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of novel diarylpyrazole imide analogues as CB1 cannabinoid receptor ligands.
Song KS; Kim MJ; Seo HJ; Lee SH; Jung ME; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2009 Apr; 17(8):3080-92. PubMed ID: 19328001
[TBL] [Abstract][Full Text] [Related]
4. Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant.
Menozzi G; Fossa P; Cichero E; Spallarossa A; Ranise A; Mosti L
Eur J Med Chem; 2008 Dec; 43(12):2627-38. PubMed ID: 18342403
[TBL] [Abstract][Full Text] [Related]
5. Pentacycle derivatives as cannabinoid CB1 receptor ligands.
Lee SH; Seo HJ; Kim MJ; Kang SY; Lee SH; Ahn K; Lee M; Han HK; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6632-6. PubMed ID: 19850473
[TBL] [Abstract][Full Text] [Related]
6. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
Lange JH; van Stuivenberg HH; Coolen HK; Adolfs TJ; McCreary AC; Keizer HG; Wals HC; Veerman W; Borst AJ; de Looff W; Verveer PC; Kruse CG
J Med Chem; 2005 Mar; 48(6):1823-38. PubMed ID: 15771428
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships (SARs) of 1,5-diarylpyrazole cannabinoid type-1 (CB(1)) receptor ligands for potential use in molecular imaging.
Donohue SR; Halldin C; Pike VW
Bioorg Med Chem; 2006 Jun; 14(11):3712-20. PubMed ID: 16466922
[TBL] [Abstract][Full Text] [Related]
9. Description of a bivalent cannabinoid ligand with hypophagic properties.
Fernández-Fernández C; Decara J; Bermúdez-Silva FJ; Sánchez E; Morales P; Gómez-Cañas M; Gómez-Ruíz M; Callado LF; Goya P; Rodríguez de Fonseca F; Martín MI; Fernández-Ruíz J; Meana JJ; Jagerovic N
Arch Pharm (Weinheim); 2013 Mar; 346(3):171-9. PubMed ID: 23371794
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.
Zhang Y; Gilliam A; Maitra R; Damaj MI; Tajuba JM; Seltzman HH; Thomas BF
J Med Chem; 2010 Oct; 53(19):7048-60. PubMed ID: 20845959
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor-ligand.
Seo HJ; Kim MJ; Lee SH; Lee SH; Jung ME; Kim MS; Ahn K; Kim J; Lee J
Bioorg Med Chem; 2010 Feb; 18(3):1149-62. PubMed ID: 20045337
[TBL] [Abstract][Full Text] [Related]
12. Solid phase synthesis of 1,5-diarylpyrazole-4-carboxamides: discovery of antagonists of the CB-1 receptor.
Pendri A; Dodd DS; Chen J; Cvijic ME; Kang L; Baska RA; Carlson KE; Burford NT; Sun C; Ewing WR; Gerritz SW
ACS Comb Sci; 2012 Mar; 14(3):197-204. PubMed ID: 22340081
[TBL] [Abstract][Full Text] [Related]
13. Probing the CB
Laprairie RB; Vemuri K; Stahl EL; Korde A; Ho JH; Grim TW; Hua T; Wu Y; Stevens RC; Liu ZJ; Makriyannis A; Bohn LM
Mol Pharmacol; 2019 Nov; 96(5):619-628. PubMed ID: 31515283
[TBL] [Abstract][Full Text] [Related]
14. F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
Shen CP; Xiao JC; Armstrong H; Hagmann W; Fong TM
Eur J Pharmacol; 2006 Feb; 531(1-3):41-6. PubMed ID: 16438957
[TBL] [Abstract][Full Text] [Related]
15. Hair growth stimulator property of thienyl substituted pyrazole carboxamide derivatives as a CB1 receptor antagonist with in vivo antiobesity effect.
Srivastava BK; Soni R; Patel JZ; Joharapurkar A; Sadhwani N; Kshirsagar S; Mishra B; Takale V; Gupta S; Pandya P; Kapadnis P; Solanki M; Patel H; Mitra P; Jain MR; Patel PR
Bioorg Med Chem Lett; 2009 May; 19(9):2546-50. PubMed ID: 19328683
[TBL] [Abstract][Full Text] [Related]
16. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
[TBL] [Abstract][Full Text] [Related]
17. Tetrazole-biarylpyrazole derivatives as cannabinoid CB1 receptor antagonists.
Kang SY; Lee SH; Seo HJ; Jung ME; Ahn K; Kim J; Lee J
Bioorg Med Chem Lett; 2008 Apr; 18(7):2385-9. PubMed ID: 18337096
[TBL] [Abstract][Full Text] [Related]
18. Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole.
Srivastava BK; Soni R; Joharapurkar A; Sairam KV; Patel JZ; Goswami A; Shedage SA; Kar SS; Salunke RP; Gugale SB; Dhawas A; Kadam P; Mishra B; Sadhwani N; Unadkat VB; Mitra P; Jain MR; Patel PR
Bioorg Med Chem Lett; 2008 Feb; 18(3):963-8. PubMed ID: 18207393
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.
Govaerts SJ; Hermans E; Lambert DM
Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124
[TBL] [Abstract][Full Text] [Related]
20. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
Lee SH; Seo HJ; Lee SH; Jung ME; Park JH; Park HJ; Yoo J; Yun H; Na J; Kang SY; Song KS; Kim MA; Chang CH; Kim J; Lee J
J Med Chem; 2008 Nov; 51(22):7216-33. PubMed ID: 18954042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
